Product Information

DORZOLAMIDE HCL 2% EYE DROPS is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.8852 per ML under NDC 62332051910. Its NADAC has been published 92 times since Feb 12, 2025.

FDA first approved this application on Aug 9, 2019. Its Orange Book therapeutic-equivalence code is AT.

DORZOLAMIDE HCL 2% EYE DROPS

Dorzolamide Hydrochloride
$0.8852per ML

Strength

20 mg/mL

NDC

62332051910

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

10/21/2026

Active Ingredients

DORZOLAMIDE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA212639

FDA Approved

8/9/2019

TE Code

AT

On Market Since

8/9/2019

Pharmacological Classes

Carbonic Anhydrase Inhibitor
Carbonic Anhydrase Inhibitors

Price Statistics

The NADAC for DORZOLAMIDE HCL 2% EYE DROPS has been published 92 times since Feb 12, 2025, and over the history we have for it it has declined 30.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.8852 per ML
All-time high$1.4058 (Jun 11, 2025)
All-time low$0.8212 (Jul 22, 2026)
52-week high$0.9289
52-week low$0.8212
Median price$0.9254
Average price$1.0275
Largest weekly change-11.5% (Aug 20, 2025)
Weeks tracked92
Tracking sinceFeb 12, 2025

Price History

1W

0.0%

1M

+6.0%

3M

+6.5%

6M

+3.5%

1Y

-5.8%

3Y

N/A

5Y

N/A

All

-30.8%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DORZOLAMIDE HCL 2% EYE DROPS?

The current National Average Drug Acquisition Cost (NADAC) for DORZOLAMIDE HCL 2% EYE DROPS, manufactured by Alembic Pharmaceuticals Inc., is $0.8852 per ML (NDC 62332051910), effective Nov 11, 2026.

How has the price of DORZOLAMIDE HCL 2% EYE DROPS changed over time?

Over the history we have for it, the NADAC for DORZOLAMIDE HCL 2% EYE DROPS has declined 30.8%. It has been tracked across 92 weekly CMS publications since Feb 12, 2025.

What are the highest and lowest recorded NADAC prices for DORZOLAMIDE HCL 2% EYE DROPS?

Since Feb 12, 2025, the NADAC for DORZOLAMIDE HCL 2% EYE DROPS has ranged from a low of $0.8212 (Jul 22, 2026) to a high of $1.4058 (Jun 11, 2025), with a median of $0.9254 per ML.

Are there cheaper alternatives to DORZOLAMIDE HCL 2% EYE DROPS?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DORZOLAMIDE HCL 2% EYE DROPS in a comparable dosage form, but none are currently priced below it.

Who manufactures DORZOLAMIDE HCL 2% EYE DROPS?

DORZOLAMIDE HCL 2% EYE DROPS (NDC 62332051910) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.